Resources

Joel Goldsmith is the Senior Director of Digital Platforms at Abbott Diabetes Care, which is focused on designing, developing, and commercializing software-based products and services that drive trial and sustained utilization of ADC's sensor-based glucose monitoring solutions. He and his team created the FreeStyle Libre system, which comprises a tiny glucose sensor (0.2 inches in length, about the thickness of a hair) inserted through the skin and connected to a small, water resistant, plastic patch on the skin’s surface.

In this Exclusive Interview, Joel Goldsmith talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about the new Freestyle Lite and Freestyle Pro CGM systems, their benefit to patients as well as clinicians, and the response thus far.

In this Exclusive Interview, Joel Goldsmith discusses how CGMs are changing diabetes management, including the Freestyle Libre system, intended for use by patients, and Freestyle Libre Pro, a solution that’s designed for clinicians.

In part 1 of this Exclusive Interview, Joel Goldsmith talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about what happened to an earlier Abbott product, the Navigator, and explains the latest CGM products, Freestyle Libre and Freestyle Libre Pro.

In part 2 of this Exclusive Interview, Joel Goldsmith talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about the differences between the Freestyle Libre and Pro systems, once of which is patient-focused, the other for clinician monitoring.

In part 3 of this Exclusive Interview, Joel Goldsmith explains the use and affordability of the Freestyle Libre system in a conversation with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California.

In part 4 of this Exclusive Interview, Joel Goldsmith talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about the effectiveness of the new CGM system in the management of diabetes.

In part 5 of this Exclusive Interview, Joel Goldsmith talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about Abbott's response to the ambulatory glucose profile recommendation by AACE.

In part 6, the conclusion of this Exclusive Interview, Joel Goldsmith talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about the response of patients to the new CGM system.

Female, 25 years of age related a story to me she recalls from years back. Patient was diagnosed with type 1 diabetes at 5 years of age. Mother has had type 1 diabetes since childhood, so patient had learned a lot about living with type 1 diabetes since a young child. Patient is and has been a very independent person. Both her mother and father trusted her and for the most part worked with her pediatrician to manage her diabetes.